Company research / CTKB
Cytek Biosciences, Inc. (CTKB)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Cytek Biosciences, Inc. reported revenue of $201.49M. Revenue grew 0.5% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $206.71M.
Key ratios (year ended 2025-12-31)
51.8%
Gross margin
-20.0%
Operating margin
-33.0%
Net margin
-19.5%
Return on year-end equity
0.5%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.